Literature DB >> 23559373

CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria.

Frank Heuts1, Dolores Gavier-Widén, Berit Carow, Julius Juarez, Hans Wigzell, Martin E Rottenberg.   

Abstract

We have used humanized mice, in which human immune cells differentiate de novo from transplanted cord blood progenitor cells, to study the human immune responses to infection with Mycobacterium bovis bacillus Calmette-Guérin and Mycobacterium tuberculosis. Granulomas with a core containing giant cells, human CD68(+) macrophages, and high bacilli numbers surrounded by a layer of CD3(+) T cells and a fibrotic response encapsulating the lesions were observed in livers and lungs from bacillus Calmette-Guérin-infected humanized mice but not in nonhumanized infected controls. Paradoxically, humanized mice contained higher mycobacterial numbers in organs than nonhumanized controls. The enhancement of bacterial load was mediated by human CD4(+) cells and associated to an increased expression of Programmed Death-1 protein and CD57 on T cells, molecules associated with inhibition and senescence. The lesions from mice depleted of CD4(+) cells were scarcer, minimal, and irregular compared with those from mice depleted of CD8(+) cells or nondepleted controls. Granulomas of bacillus Calmette-Guérin-infected humanized mice administered with a TNF-neutralizing TNF receptor fusion molecule preserved their structure, but contained higher levels of intracellular bacilli. Extended necrosis was observed in granulomas from M. tuberculosis- but not bacillus Calmette-Guérin-infected humanized mice. Our data indicate that humanized mice can be used as a model to study the formation and maintenance of human granuloma in tuberculosis and other infectious or noninfectious diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23559373      PMCID: PMC3631626          DOI: 10.1073/pnas.1219985110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.

Authors:  A M Caruso; N Serbina; E Klein; K Triebold; B R Bloom; J L Flynn
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

3.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

Review 4.  Experimental models to study development and function of the human immune system in vivo.

Authors:  Nicolas Legrand; Kees Weijer; Hergen Spits
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

5.  Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.

Authors:  H C Hänsch; D A Smith; M E Mielke; H Hahn; G J Bancroft; S Ehlers
Journal:  Int Immunol       Date:  1996-08       Impact factor: 4.823

6.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

7.  A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis.

Authors:  Minjian Chen; Huixian Gan; Heinz G Remold
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

8.  Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ.

Authors:  R J North; A A Izzo
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

9.  A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.

Authors:  K Peppel; D Crawford; B Beutler
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant.

Authors:  Hannah E Volkman; Hilary Clay; Dana Beery; Jennifer C W Chang; David R Sherman; Lalita Ramakrishnan
Journal:  PLoS Biol       Date:  2004-10-26       Impact factor: 8.029

View more
  28 in total

1.  Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.

Authors:  Ajay Grover; Amber Troy; Jenny Rowe; JoLynn M Troudt; Elizabeth Creissen; Jennifer McLean; Prabal Banerjee; Gerold Feuer; Angelo A Izzo
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

Review 2.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 3.  Animal models to study Mycobacterium tuberculosis and HIV co-infection.

Authors:  Ming Guo; Wen-Zhe Ho
Journal:  Dongwuxue Yanjiu       Date:  2014-05

4.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

5.  Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes.

Authors:  Ainhoa Perez-Diez; Xiangdong Liu; Virginia Sheikh; Gregg Roby; David F Stroncek; Irini Sereti
Journal:  JCI Insight       Date:  2019-07-25

Review 6.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

7.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

8.  Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.

Authors:  Mark T Orr; Gregory C Ireton; Elyse A Beebe; Po-Wei D Huang; Valerie A Reese; David Argilla; Rhea N Coler; Steven G Reed
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

Review 9.  Humanized Mouse Models of Clinical Disease.

Authors:  Nicole C Walsh; Laurie L Kenney; Sonal Jangalwe; Ken-Edwin Aryee; Dale L Greiner; Michael A Brehm; Leonard D Shultz
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

10.  Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis.

Authors:  Liana Tsenova; Paul O'Brien; Jennifer Holloway; Blas Peixoto; Patricia Soteropoulos; Dorothy Fallows; Gilla Kaplan; Selvakumar Subbian
Journal:  J Interferon Cytokine Res       Date:  2014-05-15       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.